Boston Tech
Suno Partners With BMG to Make AI Music Legal Enough for a Cambridge Startup
Cambridge AI music company Suno partnered with BMG on a new industry-developed model, turning copyright pressure into a serious licensing bet.
Boston Tech
Cambridge AI music company Suno partnered with BMG on a new industry-developed model, turning copyright pressure into a serious licensing bet.
Boston Tech
Burlington’s Azenta grew 12% in Q3 as biotech demand lifted sample management and multiomics, but quality costs keep the turnaround honest.
Boston Tech
MacPaw is partnering with Cambridge’s Liquid AI to bring on-device inference to developers building AI-powered Mac apps for Setapp.
Boston Tech
Salem is replacing Flock license-plate readers with city-owned cameras, forcing Massachusetts to confront who owns public-safety data and public trust.
Boston Tech
Massachusetts lawmakers passed a $575.4 million package pairing AI safety rules with robotics funding and research support. The hard part is implementation.
Boston Tech
Mass General won up to $25.8 million from ARPA-H to build a reusable gene-editing platform for rare vascular diseases in Boston and beyond for patients.
Boston Tech
Boston cybersecurity startup Neo raised $100 million to secure AI agents with endpoint controls, software inventory, and real-time policy enforcement.
Boston Tech
Hyundai is taking full control of Waltham-based Boston Dynamics as Atlas moves from viral robot demos toward factories, manufacturing, and real work.
Boston Tech
Cambridge startup Walden Robotics raised $300 million for trainable factory robots already working at Toyota, making Boston’s physical AI bet concrete.
Boston Tech
Apnimed's July 14 FDA filing acceptance puts its Cambridge sleep apnea pill AD109 on track for a February 28, 2027 review decision.
Boston Tech
Spero Therapeutics used a $105 million royalty financing and a new antibody license to turn its Utebzi approval into a Cambridge immunology reboot.
Boston Tech
FDA approved Leqembi IQLIK's at-home starting dose on July 13, giving Cambridge-based Biogen a meaningful Alzheimer's access and workflow win.